Woven EndoBridge (WEB) Aneurysm Embolization System
Microvention, Inc. · Decision date Dec 31, 2018
What did the FDA approve?
The FDA database entry records an original PMA approval for the Woven EndoBridge (WEB) Aneurysm Embolization System, an intrasaccular flow disruption device in the neurology specialty. The approval covers use in adults to embolize saccular intracranial wide neck bifurcation aneurysms in specified anterior and posterior circulation locations, with a dome diameter of 3 mm to 10 mm and a neck size of 4 mm or greater or a dome-to-neck ratio greater than 1 and less than 2.
The decision date is December 31, 2018, and the applicant is MicroVention, Inc. The entry lists no supplement type or supplement reason, so this record does not describe a change to a prior approval. The statement reports the approved scope of use; it does not by itself provide independent proof of safety or clinical effectiveness.
FDA approval order statement
Approval for use in adults to embolize saccular intracranial wide neck bifurcation aneurysms located in the anterior (middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery (AComm) complex) and posterior (basilar apex) circulations, ranging in size from 3 mm to 10 mm in dome diameter, where the neck size is 4 mm or greater or the dome-to-neck ratio is greater than 1 and less than 2.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Neurology
- Decision date
- Dec 31, 2018
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P170032
- Regulatory pathway
- Premarket approval application
- Applicant
- Microvention, Inc.
- Product code
- OPR
- Decision code
- APPR
- Decision date
- Dec 31, 2018
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intrasaccular Flow Disruption Device.
- Applicant
- Microvention, Inc.
- Product code
- OPR
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P170032 received
Application receipt date recorded by FDA.
P170032 · FDA decision
APPR
P170032/S024 · Related supplement
Woven EndoBridge (WEB) Aneurysm Embolization System
Timeline entries are records held by MedtechLedger for P170032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Microvention, Inc. | PMA supplement | Oct 27, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Microvention, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 35 Enterprise, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P170032
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records